Navigation Links
Microneedles enhance drug administration through skin
Date:2/4/2008

bjects had detectable levels of the drug in their bloodstream.

As part of the study, electrical resistance testing of the skin was done on separate subjects to determine how long the pores created by the microneedles remained open. Those tests suggested the drug could pass through treated skin for at least 48 hours before natural healing processes closed up the tiny punctures.

Beyond maintaining a steady level of the naltrexone, microneedle delivery may offer another advantage over oral administration: a reduction in the presence of compounds metabolized from the drug. The primary metabolite, known as naltrexol, is rapidly produced by the liver and intestines when the drug is administered orally, creating blood levels as much at ten times that of the parent drug which can cause undesirable side effects. With microneedle administration, however, the levels of naltrexol stayed well below those of the naltrexone.

During the first week of treatment using oral naltrexone, 10 to 20 percent of patients drop out of treatment because of side effects, Wermeling said. If you can change the way the parent drug is presented in a way that affects how the metabolites are formed, you could improve the safety or side effects of the drug.

Microneedle administration also reduced the amount of drug required to produce therapeutic levels, replacing a 50 milligram tablet with 10-12 milligrams of drug in the gel. Use of the microneedles also produced steady bloodstream levels of the drug, without the initial peak that occurs with oral delivery.

The study represents a first step in demonstrating the broad range of potential uses for microneedles, said Prausnitz, who has been developing the devices for more than ten years. In addition to Prausnitz, the Georgia Tech research team also included Harvinder Gill and Jyoti Gupta.

There are a number of ways in which microneedles can be used, Prausnitz noted. This study addressed the simplest use of microneedles in which t
'/>"/>

Contact: Ann Blackford
ann.blackford@uky.edu
859-323-6363
University of Kentucky
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. T cell immunity enhanced by timing of interleukin-7 therapy
2. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
3. Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics
4. Companys Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands
5. Technique enhances digital television viewing for visually-impaired
6. Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution
7. AAPPO and HCAA Form Partnership to Enhance Services to Meet the Changing Business Needs of PPOs and TPAs
8. Z-shaped incision enhances minimally invasive surgery
9. Z-shaped incision enhances minimally-invasive surgery
10. QLT Appoints Goldman, Sachs & Co. as financial advisor in review of strategic options to enhance shareholder value
11. Advanced Clinical Research Services Enhances Biostatistics Offering
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microneedles enhance drug administration through skin
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... as 10 million older Americans suffer from depression, often ... However, new research a project that followed the ... years found that Internet use among the elderly ... 30 percent. , "That,s a very strong effect," said ... information studies and media who led the project. "And ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2
... researchers have discovered a new method to test for ... for chromosomal abnormalities are currently done through amniocentesis and ... scientists have been able to isolate single cells of ... woman with the help of a cervical swab. This ...
... delay your chances of getting treated// for cancer early. ... of Cancer, valuable time is lost when cancer patients goes ... suspected prostate cancer might be diagnosed three times later than ... gets treated for cancer. The average time for the diagnosis ...
... of inability to read in dyslexic children is// not ... thought in recent years. Instead, the dyslexic children may ... ,Dyslexia is one type of specific learning disability. ... verbal skills, abstract reasoning, hand-eye coordination, concentration, perception, memory ...
... School of Medicine have successfully discovered how the body’s ... like leprosy in some cases but not in others. ... system often fights with the infections in the initial ... they are unable to control the bug that it ...
... suffering from chronic lower back pain for more than a ... is done when no other treatment seems to bring them ... British Medical Journal reveled that in the long run this ... do not have enough finance to sustain a long-term medical ...
... sleep apnea syndrome affects a lot of people who ... top of having a difficult night, these people may ... ,Obstructive sleep apnea syndrome (OSAS), also known as ... heart problems, stroke, obesity, breathing problems, sexual dysfunction and ...
Cached Medicine News:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Combination Clinical Trials ... SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... the company,s lead drug candidate, voreloxin (formerly,SNS-595), including updated results ... single agent in relapsed or refractory patients with acute,myeloid leukemia ...
... Requip XL Improved Symptoms in Patients Not Optimally ... "Off" Time by Nearly Two Hours Per Day, ... (NYSE: GSK ) today announced the approval ... for the treatment,of the signs and symptoms of ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 2U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 3U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 4U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: